The Smart Investor
    Facebook Instagram
    Friday, September 22
    Facebook Instagram LinkedIn
    The Smart Investor
    • Home
    • About
      • About Us
      • Careers
    • Smart Investing
      • Getting Started
      • Investing Strategy
      • Smart Analysis
      • Smart Reads
    • Special Free Reports!
    • As Featured on BT
    • Our Services
      • Our Services
      • Subscribe now!
    • Login
    • Cart
    The Smart Investor
    Home»Blue Chips»Hitting Your 50s? These 4 Stocks May Be Suitable for Your Portfolio
    Blue Chips

    Hitting Your 50s? These 4 Stocks May Be Suitable for Your Portfolio

    An increasing focus on stability and passive income should make these four stocks suitable for investors who are in their 50s.
    Royston YangBy Royston YangSeptember 24, 20215 Mins Read
    Facebook Twitter LinkedIn Email WhatsApp
    Mature Couple Smiling at Camera
    Share
    Facebook Twitter LinkedIn Email WhatsApp

    As you age, your priorities may shift.

    Therefore, it’s not surprising that investors who are in their 50s seek more certainty and stability as retirement looms.

    Contrast this with investors in their 30s or 40s who may still make do with riskier growth stocks.

    The 50s is a decade where passive income from dividends becomes all the more important as you prepare to transition to retirement.

    Hence, there is a tendency to rely on companies that have been tried and tested and that have a track record of consistent dividend payments.

    These may include dependable blue-chip companies and smaller but stable mid-cap businesses.

    Here are four stocks that may be ideal for your portfolio when you hit this age bracket.

    Venture Corporation Limited (SGX: V03)

    Venture is a provider of technology products, services and solutions.

    The group is a blue-chip contract manufacturer with a portfolio of more than 5,000 products and employs more than 12,000 people worldwide.

    Venture had witnessed some supply chain disruptions to its business last year but conditions have improved this year.

    The group reported a 4.9% year on year rise in revenue for its fiscal 2021 first half (1H2021).

    Net profit increased by 7.6% year on year to S$140.4 million.

    Free cash flow of S$161.1 million was generated for 1H2021, and an interim dividend of S$0.25 was declared and paid, similar to the prior period.

    Venture attributed the better performance to the setting up of working task forces that collaborated with a strong network of global partners and business associates.

    Moving forward, the manufacturing giant will continue to invest in developing new capabilities and growing its science and technology segment. New hires are also helping to add to the pool of diverse talent.

    Singapore Exchange Limited (SGX: S68)

    Singapore Exchange Limited, or SGX, is Singapore’s sole stock exchange operator.

    The group operates in a natural monopoly and owns a platform that allows for the buying and selling of a wide variety of securities such as equities, bonds and derivatives.

    The bourse operator had declared a final quarterly dividend of S$0.08 for its fiscal year ended 30 June 2021 (FY2021), bringing the full-year dividend to S$0.32.

    Although SGX reported a somewhat downbeat set of earnings for FY2021, the group has plans to scale up its foreign exchange, fixed income, and indices businesses.

    Recently, the group also announced that it had formulated and approved a framework for the listing of special purpose acquisition companies, or SPACs.

    SPACs represent an exciting new area of growth for SGX as these blank-cheque companies could attract promising private companies to float their shares on the exchange.

    News sources report that SGX may even see its first SPAC listing in a matter of weeks.

    Sheng Siong Group Ltd (SGX: OV8)

    Sheng Siong is a leading retailer in Singapore with a network of 63 stores around the island, mostly located in the heartland areas.

    The group offers a wide range of products including live and fresh produce as well as general merchandise such as toiletries and essential household items.

    For 1H2021, Sheng Siong saw an 8.8% year on year dip in revenue to S$681.7 million after last year’s surge in buying during the circuit breaker.

    Net profit dipped by 12.1% year on year to S$66.1 million but the group still declared an interim dividend of S$0.031.

    Sheng Siong will adopt a two-prong approach for growth — organically through improved same-store-sales, and by expanding its network of outlets in Singapore.

    Over in China, the group will be opening two more stores in Kunming, taking its total to four stores in China by the end of this year.

    Raffles Medical Group (SGX: BSL)

    Raffles Medical Group, or RMG, is an integrated private healthcare provider with operations in 14 cities across five countries in Asia.

    RMG operates its flagship Raffles Hospital in Bugis and also employs over 2,700 employees across the group.

    The group reported a pleasing set of earnings for 1H2021, with revenue jumping by 42.2% year on year to S$343.8 million and net profit more than doubling year on year to S$39.4 million from S$17.2 million.

    RMG actively assisted the government with COVID-19 vaccination and swab test initiatives that resulted in a stronger performance.

    In China, both RMG’s new hospitals in Chongqing and Beijing continue to see improved patient loads.

    The group also recently completed its new 12-storey, 400-bed hospital in Shanghai that will provide a comprehensive suite of medical services.

    RMG previously announced its intention to consolidate both its interim and final dividends into a single, annual core dividend of not less than S$0.025 per share.

    Investors can look forward to a dividend declaration once the medical services group announces its full-year 2021 earnings in February next year.

    If you want more stock ideas, start looking out for these 5 unique traits in the stock market. Companies with these traits can possibly pay you dividends for life. Discover what these traits are in your FREE special report “Dividend Stocks That Can Pay You For Life”. Click here to download now.

    Follow us on Facebook and Telegram for the latest investing news and analyses!

    Disclaimer: Royston Yang owns shares of Singapore Exchange Limited and Raffles Medical Group.

    Yahoo
    Share. Facebook Twitter LinkedIn Email WhatsApp

    Related Posts

    Word Retirement with Jar of Coins

    Looking to Accelerate Your Wealth Accumulation? Here is How to Harness the Power of Compounding

    September 21, 2023
    SGX

    SGX Announces a New Corporate Structure: Can the Bourse Operator Continue Growing its Profits and Dividends?

    September 21, 2023
    Chocolates

    5 Singapore Stocks That Paid Out Dividends in September

    September 20, 2023
    Facebook Instagram LinkedIn Telegram
    • Careers
    • Disclaimer & Privacy Policy
    • Subscription Terms of Service
    © 2023 The Smart Investor. All Rights Reserved. The Smart Investor, thesmartinvestor.com.sg, an investment education website managed by The Investing Hustle Pte Ltd (Company Reg No. 201933459Z) is not licensed or otherwise regulated by the Monetary Authority of Singapore, and in particular, is not licensed or regulated to carry on business in providing any financial advisory service. Accordingly, any information provided on this site is meant purely for informational and investor educational purposes and should not be relied upon as financial advice. No information is presented with the intention to induce any reader to buy, sell, or hold a particular investment product or class of investment products. Rather, the information is presented for the purpose and intentions of educating readers on matters relating to financial literacy and investor education. Accordingly, any statement of opinion on this site is wholly generic and not tailored to take into account the personal needs and unique circumstances of any reader. The Smart Investor does not recommend any particular course of action in relation to any investment product or class of investment products. Readers are encouraged to exercise their own judgment and have regard to their own personal needs and circumstances before making any investment decision, and not rely on any statement of opinion that may be found on this site.

    Type above and press Enter to search. Press Esc to cancel.